A new clinical tool may improve how physicians assess the severity of a painful and often debilitating skin disorder, according to a study recently published in JAMA Dermatology.

A team of researchers at Purdue University and Merck & Co. Inc., known as Merck Sharp & Dohme Corp. outside of the U.S. and Canada, has now introduced a new analytical tool that could help pharmaceutical companies boost vaccine production with rapid monitoring and analysis.

Researchers at the Eye Clinic of the University Hospital Bonn (UKB) and the University of Bonn, together with colleagues from the University of Münster and Harvard Medical School, have developed an innovative platform that allows the function of neural networks to be studied in a targeted manner.